Ticker Details
Vaxcyte, Inc.
IPO Date:	July 12, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$9.32B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.15 | 2.73%
Avg Daily Range (30 D):	$1.42 | 2.48%
Avg Daily Range (90 D):	$1.34 | 2.43%

Institutional Daily Volume
Avg Daily Volume:	.68M
Avg Daily Volume (30 D):	.73M
Avg Daily Volume (90 D):	1.1M

Trade Size
Avg Trade Size (Sh.):	60
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	59

Institutional Trades
Total Institutional Trades:	4,637
Avg Institutional Trade:	$3.77M
Avg Institutional Trade (30 D):	$3.95M
Avg Institutional Trade (90 D):	$4.27M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$8.15M
Avg Closing Trade (30 D):	$9.18M
Avg Closing Trade (90 D):	$13.26M
Avg Closing Volume:	154.54K

News

May 20, 2026 @ 1:14 PM Pfizer Expands Pneumococcal Vaccine Push With New ... Source: Vandana Singh

Mar 18, 2026 @ 11:34 PM Positive VAX-31 Phase 1/2 Adult Data Published in ... Source: Vaxcyte, Inc.

Feb 2, 2026 @ 9:05 PM Vaxcyte Announces Closing of $632.5 Million Public... Source: Globe Newswire

Jan 30, 2026 @ 4:33 AM Vaxcyte Announces Pricing of $550 Million Public O... Source: Na

Jan 22, 2026 @ 10:00 PM Vaxcyte Advances Adult and Infant Programs for VAX... Source: Vaxcyte, Inc.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$-1.97	$-2.3
Diluted EPS		$-1.97	$-2.3
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-284.3M	$-320.62M
Operating Income / Loss		$-302.78M	$-345.85M
Cost of Revenue
Net Cash Flow		$-77.65M	$86.88M
PE Ratio